Form 4 for CHRS Coherus Oncology, Inc.
Accepted 2024-02-15 00:00:00 ET · period of report 2024-02-09 · accession 0001610717-24-000060 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-02-15 | 2024-02-09 | CHRS | Wahlstrom Mats | Dir | G - Gift | $0.00 | -100.0K | 0 | -100% | $0 | |
| I | 2024-02-15 | 2024-02-09 | CHRS | Wahlstrom Mats | Dir | G - Gift | $0.00 | +100.0K | 100.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-09 | G | D | 99,988 | $0.00 | 0 | D Leonard Capital, LLC | — | — | (F2) The Reporting Person and his spouse are the members of Leonard Capital, LLC and therefore the Reporting Person may be deemed to have voting and dispositive power of shares held by Leonard Capital, LLC. |
| 2 | Common | Common Stock | 2024-02-09 | G | A | 99,988 | $0.00 | 99,988 | I | — | — |